9HHH image
Deposition Date 2024-11-21
Release Date 2025-12-10
Last Version Date 2026-06-10
Entry Detail
PDB ID:
9HHH
Keywords:
Title:
A rare open conformation for Ubl2 domain of papain-like protease C111S of SARS-CoV2
Biological Source:
Expression System(s):
Method Details:
Experimental Method:
Resolution:
1.98 Å
R-Value Free:
0.21
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
P 21 21 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Papain-like protease nsp3
Mutagens:C111S
Chain IDs:A, B
Chain Length:322
Number of Molecules:2
Biological Source:Severe acute respiratory syndrome coronavirus 2
Primary Citation
Structural analysis of the flexibility of the Ubl2 domain within the papain-like protease of SARS-CoV-2.
Acta Crystallogr.,Sect.F 82 222 230 (2026)
PMID: 42148530 DOI: 10.1107/S2053230X26003699

Abstact

The papain-like protease (PLpro) of SARS-CoV-2 is part of the multi-domain nonstructural protein 3 (NSP3) and consists of two domains: a ubiquitin-like domain 2 (Ubl2) and a protease domain. PLpro plays a crucial role in the replication cycle of SARS-CoV-2, facilitating host immune-system evasion and the formation of double-membrane vesicles where replication occurs. While the function of the Ubl2 domain is still not clear, it is critical for the stability and the functional efficiency of PLpro. Despite its predicted inherent flexibility, nearly all SARS-CoV-1 and SARS-CoV-2 PLpro crystal structures deposited in the Protein Data Bank show the Ubl2 domain in a highly similar, closed conformation against the catalytic domain. Here, we present a crystal structure of PLpro exhibiting Ubl2 in two distinct conformations: the well characterized closed state, where Ubl2 is positioned near the PLpro domain, and an as yet uncharacterized open state, where Ubl2 is displaced by 4 A from the PLpro core. This conformational variability in our structure appears to be related to the occupancy of a zinc ion within the zinc-finger domain. These results provide new insights into the flexibility of Ubl2, suggesting potential avenues for targeting and harnessing this dynamic behaviour for drug discovery.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback